- FATE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Fate Therapeutics (FATE) S-8Registration of securities for employees
Filed: 9 Jun 22, 4:40pm
Exhibit 107
CALCULATION OF REGISTRATION FEE
Form S-8
(Form Type)
Fate Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Offering Price Per Share(2) | Maximum Offering Price | Fee Rate | Amount of Registration Fee | |||||||
Equity | Common Stock, $0.001 par value per share, 2022 Stock Option and Incentive Plan | Rule 457(c) and Rule 457(h) | 9,500,000(3) | $22.83 | $216,885,000.00 | $0.0000927 | $20,105.24 | |||||||
Total Offering Amounts | $216,885,000.00 | — | ||||||||||||
Total Fees Previously Paid | — | |||||||||||||
Total Fee Offsets | — | |||||||||||||
Net Fee Due | $20,105.24 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of common stock which become issuable under the above-named plan by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock. |
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act, and based on the average of the high and low sales prices of the registrant’s common stock, as quoted on the Nasdaq Global Market, on June 2, 2022. |
(3) | Represents 9,500,000 shares of common stock that were reserved for issuance under the 2022 Stock Option and Incentive Plan. |